JSPR
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Jasper Therapeutics reported positive updated data from briquilimab studies in urticariaJan 8, 2026
- Jasper Therapeutics reported positive preliminary data from ETESIAN study of Briquilimab in asthma and findings from BEACON study internal investigationDec 2, 2025
- Jasper reports positive data from 180mg cohort of Briquilimab in chronic inducible urticariaJun 16, 2025